AARTIPHARM / NSE / Biotechnology & Drugs
Aarti Pharmalabs
1Y Price Trend
Key Information
Recommendations
Target High971.5
Target Low583.85
Target Mean0
Target Median0
Risk Metrics
Overall RiskBalanced risk
Board Risk42.93
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Aarti Pharmalabs Yearly results, Financial Summary The Economic Times
Aarti Pharmalabs Ltd is Rated Sell Markets Mojo
Buy, sell or hold: Hitachi Energy, Union Bank, Aarti Pharmalabs, Coal India, Petronet, Balaji Amines — Ask Profit MSN
Aarti Pharmalabs targets 15-18% revenue and EBITDA growth over 3-4 years scanx.trade
Aarti Pharmalabs Insider Ups Holding During Year simplywall.st
Aarti Pharmalabs Ltd (BOM:543748) Q4 2026 Earnings Call Highlights: Revenue Growth Amidst ... By GuruFocus Investing.com Canada
Aarti Pharmalabs uploads Q4FY26 earnings call recording scanx.trade
Aarti Pharmalabs Q4 Results: Shares slide 6% as forex loss, one-offs impact earnings performance CNBC TV18
Stock FAQs
What is the symbol and ISIN of Aarti Pharmalabs?
Aarti Pharmalabs has the symbol AARTIPHARM and ISIN - INE0LRU01027.
What is the current price of Aarti Pharmalabs?
Aarti Pharmalabs is currently trading at INR 706.40.
What are the year high and year low of Aarti Pharmalabs?
Aarti Pharmalabs has a year high of INR 971.50 and a year low of INR 583.85.
What is the market capitalization of Aarti Pharmalabs?
Aarti Pharmalabs has a market capitalization of INR 6,409.96 crore.
What is the P/E ratio of Aarti Pharmalabs?
Aarti Pharmalabs has a P/E ratio of 28.53.
What is the dividend yield of Aarti Pharmalabs?
Aarti Pharmalabs has a dividend yield of 0.50%.
How is the financial performance of Aarti Pharmalabs based on revenue, net income, and EPS?
Aarti Pharmalabs has revenue of INR 18,194.43 crore, net income of INR 1,747.07 crore, and EPS of INR 20.81.
What is the book value of Aarti Pharmalabs?
Aarti Pharmalabs has a book value of INR 220.69.
What is the debt-to-equity ratio of Aarti Pharmalabs?
Aarti Pharmalabs has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Aarti Pharmalabs?
Aarti Pharmalabs has a price-to-book ratio of 3.20 and a price-to-sales ratio of 0.35.
© SharekeyX | Rusaka Technologies 2024-2026